Most Read This Week
- Efficacy and Safety of Prostate Radiotherapy in Patients With De Novo Metastatic Castration-Sensitive Prostate Cancer
- ASH 2024: Tafasitamab Tied to Improved Progression-Free Survival in Follicular Lymphoma
- ASH 2024: Early Antibiotic Deescalation Cuts Mortality in Hematologic Cancer Patients With Febrile Neutropenia
- 2024 Top Story in Metastatic Breast Cancer: Epidemiology of Early vs Late Recurrence Among Women With Early-Stage ER+ Breast Cancer
- De-Escalated Neoadjuvant Weekly Nab-Paclitaxel With Trastuzumab and Pertuzumab vs Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab for HER2-Positive Early Breast Cancer
Recently Updated
- Immune and Gene-Expression Profiling in Estrogen Receptor–Low and –Negative Early Breast Cancer
- Obecabtagene Autoleucel for Adults With B-Cell Acute Lymphoblastic Leukemia
- Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
- Arsenic in Drinking Water Tied to Kidney Cancer Risk
- The Efficacy of Continuing Osimertinib With Platinum Pemetrexed Chemotherapy Upon Progression in Patients With Metastatic NSCLC Harboring Sensitizing EGFR Mutations